Entyvio Safe, Effective for Ulcerative Colitis and Crohn’s, Studies Show

Entyvio Safe, Effective for Ulcerative Colitis and Crohn’s, Studies Show
Entyvio (vedolizumab) is safe and effective to treat adults with moderate-to-severe active ulcerative colitis (UC) and Crohn’s disease (CD). These results come from eight real-world analyses presented by Takeda Pharmaceutical Company at 2017 Digestive Disease Week conference in Chicago, Illinois, May 6-9. Two analyses conducted by the U.S. VICTORY (Vedolizumab for Health OuTComes in InflammatORY Bowel Diseases)

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *